Page 8 - Pharma Sector

Stuck in Sydney hotel, Astra CEO defended Covid vaccine and made mega deal

AstraZeneca announced Saturday it plans to buy rare-disease specialist Alexion Pharmaceuticals in a $39 billion deal

AstraZeneca to buy Alexion for $39 billion to expand in immunology

AstraZeneca is one of the frontrunners in the drugs industry's search for a Covid-19 vaccine

Steady sales, Covid-treatment portfolio could drive pharma rerating

Better US prospects, India recovery, boosting sector's outlook

Play markets for medium-term, diversify across asset classes: Amit Khurana

IT Services has been the biggest beneficiary of Covid-19 pandemic and is now a mainstream growth driver rather than a one-off line item

Domestic drug market shows resilience, posts strong growth in October

Maintains the growth momentum from September with a 9.6 per cent growth

Sun Pharma's Q2 net profit rises 70% on one-time tax credit

Revenues remain flat, sequential improvement in India and US revenues

Apprentice hiring: Over a third of firms are gender neutral, open to LGBTQ

Covid-19 pandemic impacts hiring, with more resilient sectors reporting strong sentiment even as others appear to have reduced appointments

Despite volume lag, drug firms hike price as domestic sales rebound

Motilal Oswal analysts also said that while price growth for non-NLEM products stood at 4.8 per cent YoY, NLEM products saw a price rise of 3.6 per cent

E-commerce industry sees order volume growth of 31% during July-Sept 2020

After the lockdown was lifted across the country, this was the first quarter in which businesses were operational in a large part of the country

Govt invites LatAm, Caribbean nations to invest in India's pharma sector

Chemicals and Fertilisers Minister D V Sadananda Gowda on Wednesday invited Latin American and Carribean countries to invest in the Indian pharma sector

Piramal Pharma readies war chest for potential acquisition targets

A decade after Piramal sold its domestic formulations business to Abbott Laboratories for $3.72 billion, the group is now looking at re-entering the space in India

After 29% rally in H1FY21, the best in a decade, analysts cautious on mkts

Economists caution that the demand for goods and services could taper off in the months ahead

Export boost to help pharma sector come out unscathed from Covid-19: CRISIL

Exports and domestic formulations account for an almost equal share in the Rs 2.8-trillion domestic pharma sector, CRISIL said

New players enter hand sanitiser biz, consolidation certain, say FMCG firms

Industry estimates are that the domestic hand sanitiser market, which, before the pandemic stood at Rs 60 crore in size, has now grown five times to touch Rs 300 crore in size

E-commerce, IT, telecom and pharma buck lockdown trend, stay resilient

Confined indoors, people veered towards over-the-top (OTT) platforms and ordering everything online

Chemcon IPO: How momentum in the pharma sector is positive for the company

Chemcon Speciality is the only manufacturer of HMDS in India & 3rd largest worldwide. Besides, it is the largest player of CMIC in India. Both these chemicals are predominantly used in pharma sector

Apollo Hospitals reports Q1 pre-tax loss of Rs 267 cr, revenue down 16%

The chain's health care services and clinics were under pressure during the quarter, while pharmacy biz showed positive growth in revenue and profitability

Gilead nears deal to buy Immunomedics for more than $20 billion: Report

Discussions between Gilead and Immunomedics were initially centered around a partnership before shifting to a full-fledged takeover negotiation

RBI debt restructuring scheme to benefit resilient sectors more: Crisil

Crisil said it studied its rated portfolio of more than 8,500 companies after sorting them by rating, sector and moratorium availed

Vaccine majors see sharp rally with some players rising more than 4,000%

The Indian pharmaceutical sector has also been going through a surge